speb/financial-data huggingface dataset:
INDOCO.NS income_statement (quarterly, 2025-12-31) — EBIT: -56700000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — EBITDA: 263400000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 3139200000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 256400000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 256400000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Minority Interests: -3400000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Net Income: -297900000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -297900000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -294500000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -297900000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -297900000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -294500000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -256400000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -256400000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 324900000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Normalized Income: -240053465.35
INDOCO.NS income_statement (quarterly, 2025-12-31) — Operating Income: -5000000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 4343400000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 9800000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1690900000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Pretax Income: -313100000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1204200000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 320100000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Research And Development: 183100000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: -61500000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -3653465.35
INDOCO.NS income_statement (quarterly, 2025-12-31) — Tax Provision: -18600000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.06
INDOCO.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 4348400000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -61500000.00
INDOCO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -61500000.00
INDOCO.NS income_statement (annual, 2026-03-31) — +Operating Expense: 12358500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 2976700000.00
INDOCO.NS income_statement (annual, 2026-03-31) — +Total Revenue: 17929400000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 4559000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 3085200000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3085200000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 4891700000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 4891700000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 234100000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 234100000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 145600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 145600000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 84202335.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Basic EPS: -2.57
INDOCO.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 70600000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1253500000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure Reported: -1253500000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 539000000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 539000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 184600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 184600000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 259300000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 259300000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 458400000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 458400000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -19100000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 410300000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -313000000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 584000000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Change In Payable: 1131900000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -1710700000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 609200000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 58800000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Common Stock: 184600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 184600000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 9392800000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 9392800000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 13000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 282900000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 282900000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 5417400000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1410100000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Current Assets: 11933500000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 11933500000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 115600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 115600000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Current Debt: 5198300000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 5198300000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 5313900000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 5313900000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 10525400000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 10525400000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 468800000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 468800000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Depreciation: 1069000000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 1069000000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 1264500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 324900000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 1264500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 324900000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 84202335.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: -2.57
INDOCO.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: -951500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -216400000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 0.00
INDOCO.NS income_statement (annual, 2026-03-31) — EBIT: 157400000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — EBIT: 209200000.00
INDOCO.NS income_statement (annual, 2026-03-31) — EBITDA: 1421900000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — EBITDA: 534100000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — End Cash Position: 129400000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -1330900000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1010000000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 6000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Goodwill: 215200000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 215200000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 2009300000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2009300000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 10821900000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 10821900000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Gross Profit: 12512000000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 3148900000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Interest Expense: 1222500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 459200000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 1222500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 459200000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -891400000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 176900000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Inventory: 4052100000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 4052100000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 19751300000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 19751300000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -873800000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 145600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 145600000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 13000000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 530000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 423400000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 423400000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 5160200000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 5160200000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5583600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 5583600000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Long Term Debt Issuance: 530000000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -681700000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Minority Interest: -71700000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: -71700000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Minority Interests: 35500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 20400000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -1077900000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 13000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Net Debt: 10099200000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 10099200000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: -92400000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Net Income: -951500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Net Income: -216400000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: -951500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -216400000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: -987000000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -236800000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -951500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -216400000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -951500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -216400000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: -85900000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: -987000000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -236800000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Net Interest Income: -1222500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -459200000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 0.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -323800000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -151700000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -1222500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -459200000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -20900000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Net PPE: 10821900000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 10821900000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: 442600000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -172100000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 7383500000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 7383500000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 43600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 43600000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 356500000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 356500000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1451300000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 496700000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Normalized Income: -924255797.58
INDOCO.NS income_statement (quarterly, 2026-03-31) — Normalized Income: -251825280.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 2263500000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Operating Income: 153500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Operating Income: 172200000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Operating Revenue: 17929400000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 4559000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 92173705.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 92173705.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 2035100000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 2035100000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 582600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 582600000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 9208200000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 9208200000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 1794100000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1794100000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 708000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 989600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 989600000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Liabilities: 75000000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 75000000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 33300000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -400000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 6565500000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 1577200000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Other Properties: 10539000000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 10539000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 46500000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 46500000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 199100000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 199100000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Payables: 3085200000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Payables: 3085200000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Pretax Income: -1065100000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Pretax Income: -250000000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 131500000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -1077900000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 5417400000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1410100000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 1069000000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 324900000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -681700000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Research And Development: 795400000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Research And Development: 177600000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Restructuring And Mergern Acquisition: 29400000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: -37400000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 0.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 442600000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Share Issued: 92303605.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 92303605.00
INDOCO.NS income_statement (annual, 2026-03-31) — Special Income Charges: -29400000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 37400000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 6000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 9392800000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 9392800000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 7383500000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 7383500000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: -2155797.58
INDOCO.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 1974720.00
INDOCO.NS income_statement (annual, 2026-03-31) — Tax Provision: -78100000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -13200000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.07
INDOCO.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.05
INDOCO.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 215600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 215600000.00
INDOCO.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -59300000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Total Assets: 25932700000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 25932700000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 14553000000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 14553000000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Total Debt: 10897500000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 10897500000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 9321100000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 9321100000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Total Expenses: 17775900000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 4386800000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 16611600000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 16611600000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 13999100000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 13999100000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6086200000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 6086200000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Total Unusual Items: -29400000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 37400000.00
INDOCO.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: -29400000.00
INDOCO.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 37400000.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Treasury Shares Number: 129900.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 129900.00
INDOCO.NS balance_sheet (annual, 2026-03-31) — Working Capital: 1408100000.00
INDOCO.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 1408100000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -736630000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 0.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -68440000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Amortization: 12890000.00
INDOFARM.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 12890000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 48051600.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Basic EPS: 2.86
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1104660000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 1940000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 17540000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 48051600.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Diluted EPS: 2.86
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 10570000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 466810000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 74180000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 788770000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Interest Income: 1120000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 1120000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 165670000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 1361810000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Non Current Accrued Expenses: 0.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 16350000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: -20000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 46920000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Other Payable: 122160000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Other Special Charges: 19980000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 94790000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 729920000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 9490000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 9490000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Research And Development: 4600000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 1967140000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 420950000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 495130000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Special Income Charges: -20210000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 15300000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -20090000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -20090000.00
INDOFARM.NS balance_sheet (annual, 2022-03-31) — Work In Process: 438250000.00
INDOFARM.NS income_statement (annual, 2022-03-31) — Write Off: 230000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — +Operating Expense: 875890000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — +Total Revenue: 3702300000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 309240000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 743930000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -815020000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 0.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -68440000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Amortization: 9790000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 9790000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1960000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 48051600.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Basic EPS: 3.20
INDOFARM.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 19480000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1104740000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -94710000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 0.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 187760000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 17590000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 36260000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 2010000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 15580000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Change In Inventory: 6130000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 15750000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -15350000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Change In Payable: -159000000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Change In Receivables: -81310000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -233780000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -1900000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Common Stock: 187760000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 2903740000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 113420000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 2324900000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Current Assets: 3107750000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 0.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Current Debt: 1708070000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 1708070000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 2174940000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 38240000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Depreciation: 78450000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 88240000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 88250000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 78460000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 48051600.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Diluted EPS: 3.20
INDOFARM.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 153720000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 40000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — EBIT: 477190000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — EBITDA: 565440000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — End Cash Position: 17580000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 670000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -219910000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 375190000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 207040000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -40000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 40000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 87270000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 59720000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 812370000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2932170000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Gross Profit: 1377400000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Interest Expense: 254690000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 254690000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Interest Income: 1960000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 1960000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -276430000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 1960000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Inventory: 1628850000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 5710270000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -83740000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 2630000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 165670000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 0.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 1098460000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 1098460000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 13430000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 1548340000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Net Debt: 2788940000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Net Income: 153720000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 153720000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 153720000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 153720000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 153720000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 222500000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 153720000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Net Interest Income: -274470000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 8930000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 56520000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -22900000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -274470000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: 10000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Net PPE: 2117150000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -94680000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 79420000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 2844020000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Non Current Accrued Expenses: 0.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 9600000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 0.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 12870000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 577220000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Normalized Income: 161858802.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 301750000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Operating Income: 501510000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Operating Revenue: 3702300000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 48051600.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 24580000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 10000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 59720000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 274470000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 10000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 10000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 1560000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 28290000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Other Payable: 106480000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 587600000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 18670000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Other Special Charges: 11780000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Payables: 428620000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 2500000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 84360000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Pretax Income: 222500000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 3790000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -94710000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 795010000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 2324900000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 88240000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 9700000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 9700000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Research And Development: 4900000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 2113130000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 30000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 237780000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 325050000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Share Issued: 48051600.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Special Income Charges: -11780000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 2903740000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 2844020000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -3641198.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Tax Provision: 68780000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.31
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 2170000.00
INDOFARM.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -55960000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Total Assets: 6228410000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 4002200000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Total Debt: 2806530000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 2903740000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Total Expenses: 3200790000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 3324670000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 3120670000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 1149730000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 21740000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 12900000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -11780000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -11780000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Work In Process: 458650000.00
INDOFARM.NS balance_sheet (annual, 2023-03-31) — Working Capital: 932810000.00
INDOFARM.NS income_statement (annual, 2023-03-31) — Write Off: 0.00
INDOFARM.NS income_statement (annual, 2024-03-31) — +Operating Expense: 933652000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — +Total Revenue: 3746875000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 350482000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1043986000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -873259000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 0.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -68435000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Amortization: 19021000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 19021000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 9880000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 48051600.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Basic EPS: 3.21
INDOFARM.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 17585000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 1126444000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -91164000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 16254000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 375516000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 140560000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 152456000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 2331000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 138229000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -19675000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 25693000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -8393000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Change In Payable: 41238000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -217656000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -178793000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 122975000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Common Stock: 375516000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 3170624000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 51466000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 2284188000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Current Assets: 3555791000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 1713000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Current Debt: 1868819000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 1870532000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 2374565000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 41266000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Depreciation: 84115000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 103136000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 103136000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 84115000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 48051600.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Diluted EPS: 3.21
INDOFARM.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 154028000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 50000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — EBIT: 504292000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — EBITDA: 607428000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — End Cash Position: 140560000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1361000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -256982000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 334723000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 314661000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -733000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -40000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 93106000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 49629000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 1112421000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 2891768000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Gross Profit: 1462687000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Interest Expense: 265362000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 265362000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Interest Income: 2053000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 2053000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -283092000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 2053000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Inventory: 1648528000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 5876010000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -25868000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 11241000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 0.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 105217000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 14541000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 836567000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 851108000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 19178000.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1608641000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 0.00
INDOFARM.NS balance_sheet (annual, 2024-03-31) — Net Debt: 2564826000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Net Income: 154028000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 154028000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 154028000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 154028000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 154028000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 238930000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 154028000.00
INDOFARM.NS income_statement (annual, 2024-03-31) — Net Interest Income: -281039000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -1153000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -101144000.00
INDOFARM.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -240732000.00